![](/img/cover-not-exists.png)
Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on “Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the
Landi, Doriana, Centonze, Diego, Marfia, Girolama Alessandra, Capra, Ruggero, Scarpazza, CristinaLanguage:
english
Journal:
Journal of Clinical Apheresis
DOI:
10.1002/jca.21616
Date:
February, 2018
File:
PDF, 297 KB
english, 2018